iifl-logo-icon 1

Genpharmasec Ltd Share Price

2.91
(-0.34%)
Oct 8, 2024|03:50:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2.96
  • Day's High3.04
  • 52 Wk High7.31
  • Prev. Close2.92
  • Day's Low2.78
  • 52 Wk Low 1.92
  • Turnover (lac)31.59
  • P/E292
  • Face Value1
  • Book Value1.16
  • EPS0.01
  • Mkt. Cap (Cr.)161.13
  • Div. Yield0
View All Historical Data
No Records Found

Genpharmasec Ltd KEY RATIOS

Sector

Trading

Open

2.96

Prev. Close

2.92

Turnover(Lac.)

31.59

Day's High

3.04

Day's Low

2.78

52 Week's High

7.31

52 Week's Low

1.92

Book Value

1.16

Face Value

1

Mkt Cap (₹ Cr.)

161.13

P/E

292

EPS

0.01

Divi. Yield

0

Genpharmasec Ltd Corporate Action

5 Aug 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

27 Jun 2024

12:00 AM

AGM

Announcement Date: 27 Jun, 2024

arrow

27 Jun 2024

12:00 AM

BookCloser

arrow

3 Jan 2024

12:00 AM

Rights

arrow

Genpharmasec Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Genpharmasec Ltd SHAREHOLDING SNAPSHOT

09 Oct, 2024|05:40 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 29.97%

Foreign: 29.97%

Indian: 0.00%

Non-Promoter- 0.01%

Institutions: 0.00%

Non-Institutions: 70.01%

Custodian: 0.00%

Share Price

Genpharmasec Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

55.37

27.69

27.69

27.69

Preference Capital

0

0

0

0

Reserves

9.2

-12.36

-12.32

-7.02

Net Worth

64.57

15.33

15.37

20.67

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

21.3

16.5

0.08

0.47

yoy growth (%)

29.12

20,146.99

-82.94

0

Raw materials

-19.2

-15.23

0

-0.41

As % of sales

90.11

92.33

0

86.94

Employee costs

-0.18

-0.12

-0.01

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

1.5

1.2

0.06

0.01

Depreciation

-0.01

0

0

0

Tax paid

-0.25

-0.19

-0.01

0

Working capital

4.08

7.76

-0.02

0.09

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

29.12

20,146.99

-82.94

0

Op profit growth

84.44

-2,632.19

-56.97

-43.54

EBIT growth

25.23

1,775.51

389.08

-175.99

Net profit growth

24.57

2,016.97

210.4

-84.48

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023

Gross Sales

30.41

25.52

Excise Duty

0

0

Net Sales

30.41

25.52

Other Operating Income

0

0

Other Income

0.66

0.1

Genpharmasec Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,166.15

120.223,43,869.94602.260.047,800.75145.96

Aegis Logistics Ltd

AEGISLOG

683.75

47.4923,887.31165.410.48732.1367.87

Cello World Ltd

CELLO

871.75

285.719,373.8316.760.16259.9565.65

Redington Ltd

REDINGTON

184.8

13.8414,431.56155.673.3610,301.5946.35

Honasa Consumer Ltd

HONASA

444.05

109.2414,016.1634.790498.434.63

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Genpharmasec Ltd

Management

Register Office

Registrar Office

Non-Exec & Non-Independent Dir

Rajesh Sadhwani

Non-Exec & Non-Independent Dir

Sneha Sadhwani

Independent Non Exe. Director

Siddhesh Shankar Shende

Independent Director

Mayur Bharatbhai Bhatt

Independent Director

Sachin Aphandkar

Whole Time Director & CFO

Mr. Sohan Chaturvedi

Company Sec. & Compli. Officer

Hardik Makwana

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Genpharmasec Limited was originally incorporated as Public Limited Company on 16th November, 1992 in the State of Gujarat as Adi Rasayan Limited. The Company had received Certificate for Commencement of Business from ROC, Gujarat on November 20, 1992. Further, the name of Company was changed from Adi Rayasan Limited to Genpharmasec Limited on 27th November, 2018. Thereafter, the name of the Company was once again changed from Generic Pharmasec Limited to Genpharmasec Limited on 25th October, 2021 a fresh Certificate of Incorporation consequent upon the name change was obtained from the Registrar of Companies at Mumbai.The company implemented a project to manufacture organic and inorganic chemicals, dyes and pigments, at Panoli, Gujarat. Initially, the Company started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and from 2018 onwards, ity shifted business activities to buying, selling and distribution of all kinds of pharmaceutical, medicinal and medicated preparations and decided to venture into the securities market. In year 2019, the Company focused to the lucrative medical and diagnostics device segment. The Company tied up with Abbott Point of Care Corporation INC, USA for distribution of their niche diagnostic equipment namely, i-STAT 1 Analyzer which is a hand-held blood analyzer exclusively used in ICUs and ICCUs of hospitals for immediate test results.
Read More

Company FAQs

What is the Genpharmasec Ltd share price today?

The Genpharmasec Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹2.91 today.

What is the Market Cap of Genpharmasec Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Genpharmasec Ltd is ₹161.13 Cr. as of 08 Oct ‘24

What is the PE and PB ratio of Genpharmasec Ltd?

The PE and PB ratios of Genpharmasec Ltd is 292 and 2.50 as of 08 Oct ‘24

What is the 52 Week High and Low of Genpharmasec Ltd?

The 52-week high/low is the highest and lowest price at which a Genpharmasec Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Genpharmasec Ltd is ₹1.92 and ₹7.31 as of 08 Oct ‘24

What is the CAGR of Genpharmasec Ltd?

Genpharmasec Ltd's CAGR for 5 Years at -19.67%, 3 Years at -14.73%, 1 Year at 24.26%, 6 Month at 12.74%, 3 Month at 24.79% and 1 Month at -14.37%.

What is the shareholding pattern of Genpharmasec Ltd?

The shareholding pattern of Genpharmasec Ltd is as follows:
Promoters - 29.98 %
Institutions - 0.00 %
Public - 70.02 %

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp